Heart Support Australia a Finalist for Outstanding Patient Campaign at the Patients Australia Awards Gala 2025

Heart Support Australia is pleased to announce that we are a Finalist for Outstanding Patient Campaign at the Patients Australia Awards Gala for 2025. 

This is a reflection of the work we do nationally to help support and advocate for patients living with heart disease. Being a finalist shows how our campaigns and in particular our Know Your Numbers Treat Your Risk campaign is respected nationally by our peers in raising awareness of cholesterol and heart disease. 

Heart Support Australia welcomes the Federal Government announcement to extend the Heart Health Checks until 2028

Heart Support Australia is pleased to announce that our collaborative advocacy campaign in conjunction with the Heart Foundation and other key stakeholders to save the Medicare Heart Health Check has been saved after the recent budget announcement.

Following the budget announcement the Heart Health Check will be extended for another 3-years, and will no doubt continue to save thousands of lives and identify those who are at risk of developing cardiovascular disease and intervene earlier to address key risk factors.

Heart Support Australia wishes to thank the Heart Foundation who led this key advocacy campaign in conjunction with the other key stakeholders within the sector including Her Heart, ACRA, Australian Cardiovascular Alliance, Hearts4heart, Heart of the Nation, CSANZ, Baker Heart and Diabetes Institute and the Victor Chang Cardiac Research Institute.

If you are aged 45 years or older, a diabetic or First Nations person, please click here to learn more about a Heart Health Check

Confronting cholesterol: bringing it all together to solve Australia’s ASCVD crisis report.

Confronting cholesterol: bringing it all together to solve Australia’s ASCVD crisis report.

 

Heart Support Australia was pleased to work with leading experts across Australia to create this important evidence-based report focused on optimising lipid levels for people with atherosclerotic cardiovascular disease (ASCVD) in Australia. The report outlines five key recommendations to improve secondary prevention practices, with a particular emphasis on lipid management.

The report was independently prepared by Evohealth, a specialist health advisory firm, in partnership with an expert Advisory Committee and informed by interviews with stakeholders comprising of clinicians, research leaders, patient advocates and a comprehensive review of published and grey literature and supported by Amgen. 

The report is now live so please click here to read the summary or download the full report. 

 

SUBSCRIBE TO OUR NEWSLETTER